This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.

This advisory reviews diabetes and how it relates to mental illness, stress, and substance use disorders. It highlights ways to integrate diabetes care into behavioral health treatment, such as screening and intake, staff education, integrated care, and counseling support.

This guide highlights behavioral health challenges facing veterans who have served in Afghanistan and Iraq. It presents challenges related to substance misuse, post-traumatic stress disorder, depression, and suicide. The guide also discusses screening tools and intervention.

This advisory answers questions about the seriousness of prescription drug misuse. It explains how people become dependent on prescription drugs, and treatment options. The advisory also offers necessary treatment resources for professionals.

This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.

This resource guide presents healthcare professionals working with people living with physical and sensory disabilities with information about substance use disorders, including risk factors and warning signs. It also discusses screening, types of substance use services, and strategies for helping clients.

This resource provides substance use treatment program administrators with information to implement tobacco-free policies and practices in treatment settings. It discusses challenges and strategies for developing clinical guidelines for treating tobacco dependence.

This advisory offers addiction counselors an introduction to tobacco use cessation during substance use treatment. It discusses screening and effective treatment approaches to quitting, and practical and supportive counseling.

This advisory equips substance use treatment and service providers with information about eating disorders and their relationship to substance use disorders. It provides an overview of screening, referrals, and evidence-based treatments for eating disorders and lists resources for more information.

This advisory defines protracted withdrawal and identifies specific withdrawal symptoms associated with alcohol, opioids, methamphetamine, cocaine, marijuana, and benzodiazepines. The advisory also explains how protracted withdrawal differs from acute withdrawal, and gives tips to help clients manage it in recovery.